316 results on '"Huang, Yurong"'
Search Results
102. Ultrasound Contrast Agent Microbubble Modeling with Bubbles Interaction
- Author
-
Li, Shuying, primary, Huang, Yurong, additional, Yu, Jinhua, additional, and Wang, Yuanyuan, additional
- Published
- 2017
- Full Text
- View/download PDF
103. Contrast-Enhanced Ultrasound Imaging Based on Bubble Region Detection
- Author
-
Huang, Yurong, primary, Yu, Jinhua, additional, Tong, Yusheng, additional, Li, Shuying, additional, Chen, Liang, additional, Wang, Yuanyuan, additional, and Zhang, Qi, additional
- Published
- 2017
- Full Text
- View/download PDF
104. Public Digital Libraries: Observations and Prospects from the Chinese Experience
- Author
-
Huang, Yurong, primary
- Published
- 2017
- Full Text
- View/download PDF
105. Analysis of the BEV Technology Progress of America, Europe, Japan and Korea Based on Patent Map
- Author
-
Huang Yurong, Zhou Jingyan, Hou Yuanyuan, and Liu Ru
- Subjects
Patent application ,business.industry ,Regional science ,Distribution (economics) ,Battery electric vehicle ,business ,Patent map - Abstract
The paper analyzed the Battery Electric Vehicle patent application trend, major country distribution, main technology layout and patentee of America, Europe, Japan and Korea based on patent information from 2006 to 2016 by using patent map method, and visualized the Battery Electric Vehicle technology progress conditions of the four countries and regions in the last decade.
- Published
- 2018
106. Clinical application of the Innovance D-dimer assay in the diagnosis of acute pulmonary thromboembolism
- Author
-
Bai, Zhuxiao, primary, Huang, Yurong, additional, Song, Chenghua, additional, Liu, Huimin, additional, Chen, Yihui, additional, Zhang, Haitao, additional, Lu, Xinhong, additional, Song, Yingbo, additional, and Zhang, Xin, additional
- Published
- 2017
- Full Text
- View/download PDF
107. Design And Implementation Of Information Representation System For Intelligence Acquisition
- Author
-
Liu, Ru, primary, Li, Menghui, primary, Zhang, Huina, primary, Huang, Yurong, primary, and Zhou, Jingyan, primary
- Published
- 2017
- Full Text
- View/download PDF
108. 6-OH-BDE-47 promotes human lung cancer cells epithelial mesenchymal transition via the AKT/Snail signal pathway
- Author
-
Fang Liu, Wei Yu, Bo-Ning Cai, Le-Hui Du, Huang Yurong, and Bao-Lin Qu
- Subjects
Epithelial-Mesenchymal Transition ,Lung Neoplasms ,Health, Toxicology and Mutagenesis ,Polybrominated Biphenyls ,Vimentin ,Snail ,Biology ,Toxicology ,medicine.disease_cause ,chemistry.chemical_compound ,Cell Movement ,biology.animal ,Cell Line, Tumor ,medicine ,Humans ,LY294002 ,Epithelial–mesenchymal transition ,RNA, Messenger ,RNA, Small Interfering ,Protein kinase B ,PI3K/AKT/mTOR pathway ,Pharmacology ,A549 cell ,Wound Healing ,General Medicine ,chemistry ,Immunology ,Cancer research ,biology.protein ,Snail Family Transcription Factors ,Carcinogenesis ,Proto-Oncogene Proteins c-akt ,Signal Transduction ,Transcription Factors - Abstract
Hydroxylated polybrominated diphenyl ethers (OH-PBDEs) have been detected in the various human tissues. The OH-PBDEs are suggested to be stronger endocrine-disrupting compounds than PBDEs, therefore the toxicological effects of OH-PBDEs had received lots of attention. However, there is no study about the carcinogenic effect of OH-PBDEs and their estrogen potencies on the tumorigenesis and development of cancer. In the present study, we found that 6-hydroxy-2,2',4',4'-tetrabromodiphenyl ether (6-OH-BDE-47), the most abundant OH-PBDE congeners in human serum, promoted the in vitro migration of lung cancer A549 and H358 cells by induction of epithelial to mesenchymal transition (EMT). This was confirmed by that 6-OH-BDE-47 significantly down regulated the expression of epithelial markers E-cadherin (E-Cad) and zona occludin-1 (ZO-1) while up regulated the mesenchymal markers vimentin (Vim) and N-cadherin (N-Cad). 6-OH-BDE-47 up regulated the protein while not mRNA levels of Snail, which was the key transcription factor of EMT. Silencing of Snail by use of siRNA attenuated the 6-OH-BDE-47 induced EMT. This suggested that the stabilization of Snail was essential for 6-OH-BDE-47 induced EMT. Further, the treatment of 6-OH-BDE-47 increased the phosphorylation of AKT and ERK in A549 cells. Only PI3K/AKT inhibitor (LY294002), but not ERK inhibitor (PD98059), completely blocked the 6-OH-BDE-47 induced up regulation of Snail and down regulation of E-Cad, suggesting that PI3K/AKT pathway is important for 6-OH-BDE-47-mediated Snail stabilization and EMT in A549 cells. Generally, our results revealed for the first time that 6-OH-BDE-47 promoted the EMT of lung cancer cells via AKT/Snail signals. This suggested that more attention should be paid to the effects of OH-PBDEs on tumorigenesis and development of lung cancer.
- Published
- 2014
109. Clinical analysis of intracranial germinoma’s craniospinal irradiation using helical tomotherapy
- Author
-
Qu, Baolin, Du, Lei, Huang, Yurong, Yu, Wei, Cai, Boning, Xu, Shouping, and Ma, Lin
- Subjects
Original Article - Abstract
To evaluate the short-term clinical outcomes of intracranial germinoma patients treated with craniospinal irradiation (CSI) using helical tomotherapy (HT) system in our center.Twenty-three patients who were treated with CSI in our center from January 2008 to July 2012 were collected, with an average age of 20. All of the patients' CSI used the HT system. The total doses were 27-36 Gy/15-20 F (1.5-2 Gy per fraction), and total local doses were 46-60 Gy/30-50 F (5 fractions per week). All female patients for CSI were treated with left-right parallel-opposed field irradiation to protect their ovarian functions. Median follow-up time was 30.9 months (range, 5-67 months). The SPSS19.0 software was used, and the overall survival (OS) was calculated using the Kaplan-Meier method.Among 17 patients with assessable tumors, 9 cases (52.9%) were CR, 7 cases (41.2%) were PR, and 1 case (5.9%) was SD. Hematological toxicity was the severest side-effect occurred in the procedure of CSI. The level 1-4 acute leukopenia were 8.7%, 30.4%, 34.8% and 21.7% and the level 1-4 acute thrombopenia were 8.7%, 30.4%, 21.7% and 8.7%, respectively.For primary intracranial germinomas, HT can be used to implement CSI for simplifying radiotherapy procedures, improving radiotherapy accuracy, enhancing protection of peripheral organs at risk (ORA) and guaranteeing therapeutic effects. With the acceptable acute and long-term toxicity, CSI using HT in intracranial germinoma patients can be a safe and alternative mode.
- Published
- 2014
110. Improvement of ultrasound contrast imaging with adaptive beamformer based on pulse inversion plane wave transmission
- Author
-
Huang, Yurong, primary, Yu, Jinhua, additional, Wang, Yuanyuan, additional, Li, Shuying, additional, and Chen, Yi, additional
- Published
- 2016
- Full Text
- View/download PDF
111. Development of an LC–MS/MS method for the quantitation of deoxyglycychloxazol in rat plasma and its application in pharmacokinetic study
- Author
-
Li, Rongshan, primary, Ran, Ruixue, additional, Li, Quansheng, additional, Huang, Yurong, additional, Gu, Yuan, additional, and Si, Duanyun, additional
- Published
- 2016
- Full Text
- View/download PDF
112. Analysis of Chinese Patent on Electric Vehicles
- Author
-
Huang, Yurong, primary, Hou, Yuanyuan, primary, Zhang, Huina, primary, Liu, Tong, primary, and Wu, Chensheng, primary
- Published
- 2016
- Full Text
- View/download PDF
113. Review of "Audience Engagement and the Role of Arts Talk in the Digital Era," by Lynne Conner
- Author
-
Huang, Yurong, primary
- Published
- 2015
- Full Text
- View/download PDF
114. The theoretical and experimental analysis of ultrasound contrast agent micro bubbles: The Sonovue
- Author
-
Li, Shuying, primary, Huang, Yurong, additional, Cheng, Yi, additional, Yu, Jinhua, additional, and Wang, Yuanyuan, additional
- Published
- 2015
- Full Text
- View/download PDF
115. Public Digital Libraries: Observations and Prospects from the Chinese Experience.
- Author
-
Huang, Yurong
- Subjects
- *
PUBLIC libraries , *DIGITAL libraries , *CULTURAL industries , *INTERNET , *TECHNOLOGICAL innovations - Abstract
In recent years, the digital revolution has created both challenges and opportunities for cultural industries. The ever-increasing production and diffusion of culture through new media via the Internet have profoundly challenged the basic infrastructure and modes of operation in many sectors of the cultural industries. This has been most evident in the case of heritage organizations—including public libraries—where the digital revolution has brought with it a number of significant challenges with respect to courting visitors/users and remaining relevant in the context of evolving digital technologies. This article discusses the rise and evolution of public digital libraries in the 1990s as a response to these new challenges. After formulating some observations about this global trend, which is now more than two decades old, this article discusses the case of public digital libraries in China. In particular, this article points to the importance of cultural policy for the development of this new form of cultural institution. Finally, after reviewing some of the challenges faced by most of these new digital libraries, this article discusses the importance of professional culture in addressing the changing needs of users. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
116. Analysis on the Factors Restricting the Development of Solar-thermal Power Generation Industry in China
- Author
-
Gao, Zihan, primary, Qiao, Jing, primary, Huang, Yurong, primary, Hou, Yuanyuan, primary, and Wei, Xiaochuan, primary
- Published
- 2015
- Full Text
- View/download PDF
117. Genetic Background Modulates lncRNA-Coordinated Tissue Response to Low Dose Ionizing Radiation
- Author
-
Tang, Jonathan, primary, Huang, Yurong, additional, Nguyen, David H., additional, Costes, Sylvain V., additional, Snijders, Antoine M., additional, and Mao, Jian-Hua, additional
- Published
- 2015
- Full Text
- View/download PDF
118. A Study of Chinese-English Codeswitching in NetspeakThrough the Adaptation Theory
- Author
-
Huang, Yurong, primary
- Published
- 2015
- Full Text
- View/download PDF
119. A computational design decision support tool for material waste minimisation during architectural design
- Author
-
Huang, Yurong
- Abstract
Construction activities and building materials contribute to around 40% of global carbon emissions. Existing research shows that architectural design decisions about geometry and materials can significantly influence a project's building material waste extent. However, architects currently have limited means to understand the waste implications of their formal and material decisions while they are designing. Computational design tools offer ways to integrate material waste estimates into architectural design processes to make such information more accessible to architects while they are designing and in the early stages of the design process. Accordingly, this research investigates and develops a computational design tool to assist architects with understanding the relationship between design decisions and material waste estimates to influence waste minimisation 'at the source' in early-stage design. To do this, the research has adopted a computational design research approach to create and prototype a material waste estimation and optimisation tool that can be integrated into a 3D modelling environment and used by architects in early-stage design. To inform the development of the waste tool, the research also collected qualitative data using interviews about how architects perceive the issue of material waste and current waste mitigation methods adopted in their building projects in an Australian context. The interview findings were used to inform the iterative workflow design of the waste tool. The waste tool prototype operates by connecting to an external material database, mapping material selections to a 3D model using a material layout algorithm, calculating material waste offcut quantities (residual waste), and generating optimisation outputs. The performance of the prototype has been evaluated using architectural documentation for a number of multi-unit residential buildings provided by an architectural organisation. The research demonstrates that the waste tool prototype can visualise the problem of waste in a 3D environment and in relation to architecture design models and generate optimisation suggestions. Enabling architects and designers to engage with a material waste optimisation tool in the early design stage aims to foster awareness of zero material waste targets by providing actionable opportunities for material reduction.
- Published
- 2023
120. C2ORF40suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes
- Author
-
Lu, Jing, primary, Wen, Mingxin, additional, Huang, Yurong, additional, He, Xiuquan, additional, Wang, Yunshan, additional, Wu, Qi, additional, Li, Zengchun, additional, Castellanos-Martin, Andres, additional, Abad, Mar, additional, Cruz-Hernandez, Juan J., additional, Rodriguez, Cesar A., additional, Perez-Losada, Jesus, additional, Mao, Jian-Hua, additional, and Wei, Guangwei, additional
- Published
- 2013
- Full Text
- View/download PDF
121. Comparison of MRI and endoscope ultrasound detection in preoperative T/N staging of gastric cancer
- Author
-
LEI, CUI, primary, HUANG, LIMING, additional, WANG, YANLIN, additional, HUANG, YILING, additional, and HUANG, YURONG, additional
- Published
- 2013
- Full Text
- View/download PDF
122. Up-regulated miR155 Reverses the Epithelial-mesenchymal Transition Induced by EGF and Increases Chemo-sensitivity to Cisplatin in Human Caski Cervical Cancer Cells
- Author
-
Lei, Cui, primary, Wang, Yanlin, additional, Huang, Yurong, additional, Yu, Han, additional, Huang, Yiling, additional, Wu, Liting, additional, and Huang, Liming, additional
- Published
- 2012
- Full Text
- View/download PDF
123. Mutation of the Nrf2 gene in non-small cell lung cancer
- Author
-
Hu, Yi, primary, Ju, Yanfang, additional, Lin, Dongmei, additional, Wang, Zhikuan, additional, Huang, Yurong, additional, Zhang, Sujie, additional, Wu, Chao, additional, and Jiao, Shunchang, additional
- Published
- 2011
- Full Text
- View/download PDF
124. Characterization of Novel Pyrovalerone Analogs as Potential Dopamine Transporter Irreversible Ligands
- Author
-
Huang, Yurong, primary, Liu, Yi, additional, Aggarwal, Shaili, additional, Indarte, Martin, additional, Manepalli, Sankar, additional, Madura, Jeffry D., additional, Surratt, Christopher K., additional, and Lapinsky, David J., additional
- Published
- 2009
- Full Text
- View/download PDF
125. Signal-quality consideration for dynamic connection provisioning in all-optical wavelength-routed networks
- Author
-
Huang, Yurong R., primary, Wen, Wushao, additional, Heritage, Jonathan P., additional, and Mukherjee, Biswanath, additional
- Published
- 2003
- Full Text
- View/download PDF
126. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas
- Author
-
Snijders, Antoine M., Liu, Yueyong, Su, Li, Huang, Yurong, and Mao, Jian-Hua
- Subjects
thymic lymphoma ,FBXW7 ,mTOR ,rapamycin ,radiation - Abstract
The tumor suppressor gene FBXW7 is deleted and mutated in many different types of human cancers. FBXW7 primarily exerts its tumor suppressor activity by ubiquitinating different oncoproteins including mTOR. Here we used gene transcript profiling to gain a deeper understanding of the role of FBXW7 in tumor development and to determine the influence of mTOR inhibition by rapamycin on tumor transcriptome and biological functions. In comparison to tumors from p53 single heterozygous (p53+/−) mice, we find that radiation-induced thymic lymphomas from Fbxw7/p53 double heterozygous (Fbxw7+/−p53+/−) mice show significant deregulation of cholesterol metabolic processes independent of rapamycin treatment, while cell cycle related genes were upregulated in tumors from placebo treated Fbxw7+/−p53+/− mice, but not in tumors from rapamycin treated Fbxw7+/−p53+/− mice. On the other hand, tumors from rapamycin treated Fbxw7+/−p53+/− mice were enriched for genes involved in the integrated stress response, an adaptive mechanism to survive in stressful environments. Finally, we demonstrated that the Fbxw7 gene signatures identified in mouse tumors significantly overlap with FBXW7 co-expressed genes in human cancers. Importantly these common FBXW7 gene signatures between mouse and human are predictive for disease-free survival in human colon, breast and lung adenocarcinoma cancer patients. These results provide novel insights into the role of FBXW7 in tumor development and have identified a number of potential targets for therapeutic intervention.
- Published
- 2015
127. Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma.
- Author
-
Yuan, Xianggui, Yu, Teng, Huang, Yurong, Jiang, Huawei, Xu, Xiaohua, Liang, Yun, and Qian, Wenbin
- Subjects
- *
RITUXIMAB , *CENTRAL nervous system , *METHOTREXATE , *INDUCTION chemotherapy , *PROGNOSIS , *REMISSION induction - Abstract
Induction chemotherapy based on high-dose methotrexate is considered as the standard approach for newly diagnosed primary central nervous system lymphomas (PCNSLs). However, the best combination chemotherapeutic regimen remains unclear. This study aimed to determine the efficacy and toxicities of rituximab with methotrexate (R-M regimen). Consecutive 37 Chinese patients receiving R-M regimen as induction chemotherapy were retrospectively identified from January 2015 to June 2020 from our center in eastern China. Fourteen patients receiving rituximab plus methotrexate with cytarabine (R-MA regimen) at the same period were identified as the positive control group. The response rates, survival, toxicities, length of hospital stay (LOS), and cost were compared. Compared with the R-MA regimen, the R-M regimen showed comparable response rate and survival outcomes, but had fewer grade 3–4 hematological toxicities, shorter LOS, lower mean total hospitalization cost and lower mean total antibiotic cost. Complete remission at the end of induction chemotherapy and ECOG > 3 were independent prognostic factors for overall survival. In conclusion, R-M regimen is an effective and cost-effective combination treatment for PCNSLs, which warrants further evaluation in randomized trials. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
128. Electric Vehicle BMS Subdivision Technology Patent Distribution Analysis.
- Author
-
Huang Yurong, Hou Yuanyuan, Zhou Jingyan, and Qiao Jing
- Published
- 2019
- Full Text
- View/download PDF
129. Epigenetic modification and exosome effects on autophagy in osteoarthritis.
- Author
-
Cheng, Chenglong, Wu, Yajie, Huang, Yurong, Xue, Qiuyun, Wang, Yuting, Liao, Faxue, Wang, Xiaomei, and Miao, Chenggui
- Subjects
- *
AUTOPHAGY , *EXOSOMES , *JOINT pain , *JOINT stiffness , *MATRIX metalloproteinases - Abstract
[Display omitted] Osteoarthritis (OA) is a degenerative disease that leads to joint pain and stiffness and is one of the leading causes of disability and pain worldwide. Autophagy is a highly conserved self-degradation process, and its abnormal function is closely related to human diseases, including OA. Abnormal autophagy regulates cell aging, matrix metalloproteinase metabolism, and reactive oxygen metabolism, which are key in the occurrence and development of OA. There is evidence that drugs directly or indirectly targeting autophagy significantly hinder the progress of OA. In addition, the occurrence and development of autophagy in OA are regulated by many factors, including epigenetic modification, exosomes, crucial autophagy molecules, and signaling pathway regulation. Autophagy, as a new therapeutic target for OA, has widely influenced the pathological mechanism of OA. However, determining how autophagy affects OA pathology and its use in the treatment and diagnosis of targets still need further research. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
130. Early exposure to thirdhand cigarette smoke affects body mass and the development of immunity in mice.
- Author
-
Hang, Bo, Snijders, Antoine M., Huang, Yurong, Schick, Suzaynn F., Wang, Pin, Xia, Yankai, Havel, Christopher, Jacob, Peyton, Benowitz, Neal, Destaillats, Hugo, Gundel, Lara A., and Mao, Jian-Hua
- Abstract
Thirdhand smoke (THS) is the fraction of cigarette smoke that persists in indoor environments after smoking. We investigated the effects of neonatal and adult THS exposure on bodyweight and blood cell populations in C57BL/6 J mice. At the end of neonatal exposure, THS-treated male and female mice had significantly lower bodyweight than their respective control mice. However, five weeks after neonatal exposure ended, THS-treated mice weighed the same as controls. In contrast, adult THS exposure did not change bodyweight of mice. On the other hand, both neonatal and adult THS exposure had profound effects on the hematopoietic system. Fourteen weeks after neonatal THS exposure ended, eosinophil number and platelet volume were significantly higher, while hematocrit, mean cell volume, and platelet counts were significantly lower compared to control. Similarly, adult THS exposure also decreased platelet counts and increased neutrophil counts. Moreover, both neonatal and adult THS exposure caused a significant increase in percentage of B-cells and significantly decreased percentage of myeloid cells. Our results demonstrate that neonatal THS exposure decreases bodyweight and that THS exposure induces persistent changes in the hematopoietic system independent of age at exposure. These results also suggest that THS exposure may have adverse effects on human health. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
131. Observation on effect of chinese herbs combined with ear buried beans adjuvant therapy for nausea and vomiting symptom in cancer patients receiving chemotherapy.
- Author
-
Huang Yurong, Hu Bifang, and Hu Pan
- Published
- 2014
- Full Text
- View/download PDF
132. RNA methylations in depression, from pathological mechanism to therapeutic potential.
- Author
-
Li, Chen, Xu, Pengfei, Huang, Yurong, Wang, Yuting, Wu, Yajie, Li, Hui, Peng, Yanhui, Wang, Xiao, Li, Guoying, He, Juan, and Miao, Chenggui
- Subjects
- *
RNA methylation , *SEX determination , *RNA modification & restriction , *MENTAL depression , *BODY mass index , *FAT - Abstract
Molecular characteristics and biological functions of RNA methylation, and the role of RNA methylation in depression. [Display omitted] Depression is caused by a variety of factors such as genetic factors, biological factors, and psychosocial factors, and the pathogenesis is complex. RNA methylations and related downstream signaling pathways influence a variety of biological mechanisms, including cell differentiation, tumorigenesis, sex determination, and stress response. In this work, we searched the PubMed, Web of Science, National Library of Science and Technology (NSTL), and ScienceDirect Online (SDOL) databases to summarize the biological roles of RNA methylations and their impact on the pathological mechanisms of depression. RNA methylations play a key role in the development of many diseases, and current research shows that RNA methylations are also closely linked to depression. RNA methylations in depression mainly involve "writers" (mediating the methylation modification process of RNAs), "erasers" (mediating the demethylation modification process of RNA methylation). Fat Mass and Obesity Associated (FTO) influences the development of depression by increasing body mass index (BMI), decreases the dopamine level, inhibits the adrenoceptor beta 2 (ADRB2)-c-Myc-sirt1 pathway, results in the m6A/m6Am dysregulation in brain, and may be involved in the pathogenesis of depression. The study of RNA methylations in depression has further deepened our understanding of the pathogenesis and development process of depression, provides new perspectives for the study of the pathological mechanism of depression, and provides new targets for the prevention and treatment of this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
133. Gandouling inhibits hepatic fibrosis in Wilson's disease through Wnt-1/β-catenin signaling pathway.
- Author
-
Cheng, Chenglong, Wang, Qiang, Huang, Yurong, Xue, Qiuyun, Wang, Yuting, Wu, Peng, Liao, Faxue, and Miao, Chenggui
- Subjects
- *
BIOLOGICAL models , *IN vitro studies , *HERBAL medicine , *IN vivo studies , *ANIMAL experimentation , *WESTERN immunoblotting , *FLUOROIMMUNOASSAY , *LIVER , *CIRRHOSIS of the liver , *WNT proteins , *CELLULAR signal transduction , *DESCRIPTIVE statistics , *HEPATOLENTICULAR degeneration , *POLYMERASE chain reaction , *PHARMACEUTICAL chemistry , *COMPUTER-assisted molecular modeling , *CHINESE medicine , *MICE , *DISEASE complications - Abstract
Wilson's disease (WD) hepatic fibrosis is the result of chronic liver injury induced by Cu2+ deposition in the liver. Gandouling (GDL) is a hospital preparation of the First Affiliated Hospital of Anhui University of Chinese Medicine. Previous studies have found that GDL can play an anti-inflammatory, anti-oxidation, and promote Cu2+ excretion, which has a clear anti-WD effect. We found that Wnt-1 was significantly up-regulated in the liver tissue of toxic-milk (TX) mouse in the WD gene mutant model, and the monomer components of GDL could combine well with Wnt-1. Therefore, in this work, we used RT-qPCR, Western blot, immunofluorescence, network pharmacology, molecular docking, and related methods to study the effects of GDL on hepatic stellate cell (HSC) activation and Wnt-1/β-catenin pathway in TX mice to clarify the effect of GDL on WD hepatic fibrosis. GDL could alleviate hepatic fibrosis, improve liver function, and inhibit the activation of HSC in TX mice. Network pharmacology predicted that the Wnt-1/β-catenin was the target of GDL, and molecular dynamics further revealed that GDL has a good binding ability with Wnt-1 and inhibits the Wnt/β-catenin signaling pathway through Wnt-1. Furthermore, we found that GDL blocked the Wnt-1/β-catenin signaling pathway in the liver of TX mice in vivo. In vitro, serum containing GDL blocked the Cu2+ ion-induced Wnt-1/β-catenin signaling pathway in LX-2 cells. Therefore, GDL blocked the Wnt-1/β-catenin signaling pathway, inhibited HSC activation, and improved WD hepatic fibrosis by binding to Wnt-1. GDL improves hepatic fibrosis in WD model mice by blocking the Wnt-1/β-catenin signaling pathway, and Wnt-1 may be a new target for the diagnosis and treatment of WD. This reveals a new mechanism of GDL against WD, and promotes the clinical promotion of GDL. Wnt-1 expression was significantly up-regulated in TX mice and Cu2+-induced LX-2 cells. Wnt-1 significantly activated the Wnt/β-catenin signaling pathway, promoted the activation of HSC, increased the levels of inflammatory cytokines TNF-α, IL-1β, and IL-6, and significantly increased the expression of α-SMA and collagen 1. GDL has an obvious therapeutic effect on TX mice. Combined with the molecular docking results, we found that GDL has a good binding ability with Wnt-1 and inhibited the Wnt/β-catenin signaling pathway through Wnt-1. This indicates that GDL exerts antifibrotic effects through the Wnt-1/β-catenin signaling pathway. [Display omitted] • Wnt-1 in Wilson's disease (WD) is significantly increased. • Wnt-1 activates the Wnt/β-catenin pathway and promotes the development of WD. • GDL reduces the expression level of α-SMA and collagen I by binding to Wnt-1. • GDL inhibits WD through the Wnt-1/β-catenin signal axis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
134. Short-term early exposure to thirdhand cigarette smoke increases lung cancer incidence in mice
- Author
-
Hang, Bo, Wang, Yunshan, Huang, Yurong, Wang, Pin, Langley, Sasha A., Bi, Lei, Sarker, Altaf H., Schick, Suzaynn F., Havel, Christopher, Jacob III, Peyton, Benowitz, Neal, Destaillats, Hugo, Tang, Xiaochen, Xia, Yankai, Jen, Kuang-Yu, Gundel, Lara A., Mao, Jian-Hua, and Snijders, Antoine M.
- Abstract
Exposure to thirdhand smoke (THS) is a recently described health concern that arises in many indoor environments. However, the carcinogenic potential of THS, a critical consideration in risk assessment, remains untested. Here we investigated the effects of short-term early exposure to THS on lung carcinogenesis in A/J mice. Forty weeks after THS exposure from 4 to 7 weeks of age, the mice had increased incidence of lung adenocarcinoma, tumor size and, multiplicity, compared with controls. In vitro studies using cultured human lung cancer cells showed that THS exposure induced DNA double-strand breaks and increased cell proliferation and colony formation. RNA sequencing analysis revealed that THS exposure induced endoplasmic reticulum stress and activated p53 signaling. Activation of the p53 pathway was confirmed by an increase in its targets p21 and BAX. These data indicate that early exposure to THS is associated with increased lung cancer risk. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
135. Huangqin Qingre Qubi Capsule inhibits RA pathology by binding FZD8 and further inhibiting the activity of Wnt/β-catenin signaling pathway.
- Author
-
Zhou, Wanwan, Wang, Yuting, Huang, Yurong, Liu, Jian, Cheng, Chenglong, Xue, Qiuyun, Wang, Xiao, Chang, Jun, and Miao, Chenggui
- Subjects
- *
REVERSE transcriptase polymerase chain reaction , *SYNOVIAL membranes , *FIBROBLASTS , *ANIMAL experimentation , *CYTOSKELETAL proteins , *PLANTS , *CELLULAR signal transduction , *RATS , *RHEUMATOID arthritis , *GENES , *COMPUTER-assisted molecular modeling , *ARTHRITIS , *CHINESE medicine - Abstract
Huangqin Qingre Qubi Capsule (HQC) is a Chinese herbal compound for the treatment of rheumatoid arthritis (RA), which is made from dry roots of Scutellaria baicalensis Georgi, dry mature seeds of Gardenia jasminoides J.Ellis , dry and mature seeds of Coix lacryma-jobi var. stenocarpa Oliv. , dry mature seeds of Amygdalus persica L. and roots and rhizomes of Clematis chinensis Osbeck in the proportion of 10:9:30:5:10. HQC has a significant effect in clinical treatment of RA, which can inhibit RA inflammation, improve oxidative stress state, and effectively relieve symptoms of RA patients. The anti-arthritis effect of HQC and its mechanism, especially whether it improves RA through FZD8-Wnt/β-catenin signal axis, were studied using adjuvant arthritis (AA) rats and FLS from RA patients. Real time qPCR (RT-qPCR), Western blot (WB), confocal microscopy and other molecular biological methods were used to study the anti-RA effect of HQC and its mechanism. The expression of FZD8 was significantly up-regulated in synovium and FLS of AA rats and RA FLS. FZD8 significantly activated the Wnt/β-catenin signaling pathway, promoted abnormal proliferation of FLS, increased the levels of inflammatory factors IL-1β, IL-6 and IL-8, and significantly increased the expression of matrix metalloproteinase 3 (MMP3) and fibronectin. HQC has significant therapeutic effect on AA rats. Molecular docking and molecular dynamics showed that HQC had a good binding ability with FZD8. We also confirmed that HQC inhibited Wnt/β-catenin signaling pathway by binding FZD8, and reduced the levels of the above inflammatory factors and pathological genes of RA. The expression of FZD8 is significantly increased in AA rats and FLS from RA patients. Clarify that HQC improves RA through the FZD8-Wnt/β-catenin signal axis, provide a clear therapeutic mechanism for HQC to improve RA, and also provide a basis for clinical promotion of HQC. FZD8 expression was significantly up-regulated in AA rats and RA FLS. FZD8 significantly activated Wnt/β-catenin signaling pathway, promoted FLS abnormal proliferation, increased the levels of inflammatory factors IL-1β, IL-6 and IL-8, and significantly increased the expression of MMP3 and fibronectin. HQC has obvious therapeutic effect on AA rats. Combining molecular docking and molecular dynamics studies, we confirmed that HQC inhibited Wnt/β-catenin signaling pathway and RA pathology by binding FZD8. [Display omitted] • The FZD8 expression was significantly up-regulated in AA rats and RA FLS. • FZD8 significantly activated Wnt/β-catenin signaling pathway and promoted RA. • HQC had a good binding ability with FZD8. • HQC improved RA through the FZD8-Wnt/β-catenin signal axis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
136. Effects of a combination of lauric acid monoglyceride and cinnamaldehyde on growth performance, gut morphology, and gut microbiota of yellow-feathered broilers.
- Author
-
Zheng, Chaojun, Chen, Zifan, Yan, Xia, Xiao, Gengsheng, Qiu, Ting, Ou, Jiancun, Cen, Mingzhu, Li, Wenlong, Huang, Yurong, Cao, Yu, and Zhang, Huihua
- Subjects
- *
LAURIC acid , *GUT microbiome , *OXIDANT status , *MORPHOLOGY , *WEIGHT gain , *DIETARY supplements , *PROTEOBACTERIA - Abstract
A total of 480 one-day-old male yellow-feathered broilers were randomly divided into 4 groups with 6 replicates of 20 chicks per replicate. A basal diet was administered to the control group (CON), whereas CML350, CML500, and CML1000 groups were fed with basal diet supplemented with 350, 500, and 1,000 mg/kg of lauric acid monoglyceride and cinnamaldehyde complex, respectively. However, adding 500 mg/kg of lauric acid monoglyceride and cinnamaldehyde complex improved weight gain (P < 0.01), enhanced intestinal morphology, increased serum total protein and albumin content, and total antioxidant capacity (P < 0.01), and significantly increased the Chao1 and Ace indices (P < 0.01), indicating an increase in the richness of the gut microbiota. At the phylum level, CML500 group reduced the abundance of Fusobacteriota at 21 d and Proteobacteria at 42 d (P < 0.01). At the genus level, CML500 group increased the abundance of Faecalibacterium and Alistipes at 42 d (P < 0.01) and decreased the abundance of Escherichia–Shigella (P < 0.01). At the species level, CML500 group reduced the abundance of Escherichia coli at 42 d (P < 0.01) and increased the abundance of AlistipespCHKCI003 at 42 d (P < 0.01). According to these results, adding 500 mg/kg of lauric acid monoglyceride and cinnamaldehyde complex in feed can improve the growth performance, intestinal morphology, and gut microbiota of yellow-feathered broilers. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
137. Clematichinenoside AR inhibits the pathology of rheumatoid arthritis by blocking the circPTN/miR-145-5p/FZD4 signal axis.
- Author
-
Wang, Xiao, Zhou, Dexi, Zhou, Wanwan, Liu, Jian, Xue, Qiuyun, Huang, Yurong, Cheng, Chenglong, Wang, Yuting, Chang, Jun, Wang, Peng, and Miao, Chenggui
- Subjects
- *
RHEUMATOID arthritis , *MOLECULAR pathology , *WNT signal transduction , *MOLECULAR dynamics , *CHINESE medicine , *PATHOLOGY , *TREATMENT effectiveness - Abstract
The Traditional Chinese medicine roots and rhizomes of Clematis chinensis Osbeck (CCO) has obvious improvement effect on rheumatoid arthritis (RA). Clematichinenoside AR (CAR) is an effective monomer of CCO and is a potential natural product for the treatment of RA. In this work, we systematically evaluated the therapeutic effect of CAR on RA model mice and its inhibitory effects on FLS proliferation and inflammation in RA. We confirmed that CAR has a good therapeutic effect on RA. CAR interfered with the circPTN/miR-145-5p signal axis by binding the FZD4, and then inhibited the role of Wnt/β-catenin signal pathway in the pathogenesis of RA. CAR has the potential to develop into a therapeutic drug for RA. [Display omitted] • CAR is an effective monomer of roots and rhizomes of Clematis chinensis Osbeck. • CircPTN/miR-145-5p signal axis promotes RA development by inhibiting the FZD4. • CAR interferes with the circPTN/miR-145-5p signal axis by targeting the FZD4. • CircPTN is an inhibitor of miR-145-5p. Traditional Chinese medicine roots and rhizomes of Clematis chinensis Osbeck (CCO) has the effect of improving rheumatoid arthritis (RA), Clematichinenoside AR (CAR) is an effective monomer of CCO and a promising natural product for the treatment of RA. In this work, we aim to systematically evaluate whether CAR can improve RA pathology, inhibit the fibroblast-like synoviocytes (FLS) proliferation and inflammatory response, and further investigate the mechanism of CAR inhibiting RA through molecular docking, molecular dynamics and molecular biology methods. Combined with the research results of CIA mice and FLS from RA patients, we found that CAR significantly improved the severity of CIA mice, and inhibited the proliferation and inflammatory response of FLS. Combined with bioinformatics prediction, we confirmed that circPTN promoted frizzled-4 (FZD4) expression through sponging miR-145-5p, then activating the Wnt/β-catenin pathway. The circPTN/miR-145-5p/FZD4 signal axis was involved in the pathogenesis of RA. Furthermore, CAR blocked the circPTN/miR-145-5p/FZD4 signal axis by combining with FZD4 and improved RA pathology. The circPTN/miR-145-5p/FZD4 signal axis plays an important role in promoting the pathogenesis of RA, and CAR from CCO may inhibit RA pathology by combining the FZD4 and further blocking this signal axis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
138. Utilizing Esophageal Motility Tests in Diagnosing and Evaluating Gastroesophageal Reflux Disease.
- Author
-
Yang W, Huang Y, He L, Chen D, Wu S, Tian Y, Zheng J, Yang J, and Song G
- Abstract
Gastroesophageal reflux disease (GERD), a prevalent clinical condition, is often attributed to aberrant esophageal motility, leading to gastric content reflux and associated symptoms or complications. The rising incidence of GERD presents an escalating healthcare challenge. Endoscopic and esophageal reflux monitoring can provide a basis for the diagnosis of patients with gastroesophageal reflux disease, but when the diagnostic basis is at an inconclusive value, some additional supportive evidence will be needed. Advanced technology is the key to improving patient diagnosis, accurate assessment, and the development of effective treatment strategies. High-resolution esophageal manometry (HREM) and endoscopic functional lumen imaging probe (EndoFLIP) represent the forefront of esophageal motility assessment. HREM, an evolution of traditional esophageal manometry, is considered the benchmark for identifying esophageal motility disorders. Its widespread application in esophageal dynamics research highlights its diagnostic significance. Concurrently, EndoFLIP's emerging clinical relevance is evident in diagnosing and guiding the treatment of coexisting esophageal motility issues. This review integrates contemporary research to delineate the contributions of HREM, EndoFLIP, and novel technologies in GERD. It examines their efficacy in facilitating an accurate diagnosis, differentiating similar gastrointestinal disorders, quantifying the extent of reflux, assessing the severity of the disease, forecasting patient responsiveness to proton pump inhibitor therapy, and guiding decisions for surgical interventions. The overarching aim is to deepen the understanding of GERD's underlying mechanisms and advance the formulation of holistic, efficacious treatment approaches.
- Published
- 2024
- Full Text
- View/download PDF
139. Huangqin Qingre Chubi Capsule inhibits rheumatoid arthritis by regulating intestinal flora and improving intestinal barrier.
- Author
-
Peng Y, Huang Y, Li H, Li C, Wu Y, Chen ZS, Wang X, Liao F, and Miao C
- Abstract
Background: Changes in intestinal flora and intestinal barrier in patients with preclinical and diagnosed rheumatoid arthritis (RA) suggest that intestinal flora and intestinal barrier play an important role in the induction and persistence of RA. Huangqin Qingre Chubi Capsule (HQC) is a clinically effective herbal formula for the treatment of RA, but its therapeutic mechanism has not been fully clarified., Materials and Methods: In this study, real-time qPCR (RT-qPCR), 16SrRNA sequencing, Western blot (WB), immunofluorescence and other methods were used to investigate whether HQC inhibited RA., Results: Based on research in collages-induced arthritis (CIA) model in mice, human colon cancer cell line (Caco-2), and fibroblast-like synoviocytes (FLS) from RA patients, we found that intestinal flora was disturbed in CIA model group, intestinal barrier was damaged, and lipolyaccharide (LPS) level was increased, and HQC could regulate intestinal flora and intestinal barrier and reduce LPS translocation into blood. Antibiotic depletion weakened the anti-RA effect of HQC, and HQC fecal microbiota transplantation alleviated RA pathology. In addition, LPS increased the expression of RA pathologic factors MMP3, Fibronectin and inflammatory factors IL-6, TNF-α, IL-1β and IL-8, indicating that elevated peripheral blood level of LPS was related to RA pathology., Conclusion: The dysregulation of intestinal flora and the disruption of intestinal barrier are significant factors in the development of RA. HQC improves RA by regulating intestinal flora, intestinal barrier and inhibiting LPS translocation into blood. The study unveiles RA's new pathogenesis and laid a scientific groundwork for advancing HQC therapy for RA., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Peng, Huang, Li, Li, Wu, Chen, Wang, Liao and Miao.)
- Published
- 2024
- Full Text
- View/download PDF
140. Ultrasound diagnosis of metastatic mucoepidermoid carcinoma in the submandibular gland: A case report.
- Author
-
Fang M, Yao W, Huang Y, and Wang X
- Abstract
Competing Interests: Declaration of competing interest The authors declare that they have no competing interests.
- Published
- 2024
- Full Text
- View/download PDF
141. Association between 23 drugs and inflammatory bowel disease: a two-sample Mendelian randomization study.
- Author
-
He L, Deng T, Huang Y, Yang W, Yang J, and Song G
- Abstract
Background: Inflammatory bowel disease (IBD) is a group of diseases characterized by chronic and recurrent inflammation of the gastrointestinal tract. The etiology of IBD remains multifaceted and poorly understood, resulting in limited treatment options that primarily target disease induction and remission maintenance. Thus, the exploration of novel therapeutic options for IBD among existing medications is advantageous. Mendelian randomization analysis (MR) serves as a valuable tool in investigating the relationship between drugs and diseases. In this study, MR analysis was employed to investigate the potential causal relationship between 23 approved drugs for the treatment of various diseases and IBD., Method: We performed a two-sample MR analysis using publicly available genome-wide association study (GWAS) statistics. The inverse variance weighting (IVW) method was used as the main analysis method, supplemented by the remaining four methods (weighted median, MR Egger regression, simple and weighted models), and Meta-analysis was performed to expand the sample size to obtain a more reliable composite causal effect. Finally, Cochran's Q statistic and the MR-Egger test for directed pleiotropy were applied to determine whether significant heterogeneity or directed pleiotropy existed., Results: In the main MR analysis (IVW), drugs with a negative causal association with the risk of IBD were immunosuppressant {OR (95% CI) = 0.7389 [0.6311-0.8651], p = 0.0046} and diabetes drugs {OR (95% CI) = 0.9266 [0.8876-0.9674], p = 0.0058}. A positive causal association with the risk of IBD was found for salicylic acid and derivatives {OR (95% CI) = 1.2737 [1.0778-1.5053], p = 0.0345}. Negative causal associations with UC risk were identified for immunosuppressants {OR (95% CI) = 0.6660 [0.5133-0.8640], p = 0.0169} and diabetes medications {OR (95% CI) = 0.9020 [0.8508-0.9551], p = 0.0046}; positive causal associations with UC risk were found for β-receptor blockers {OR (95% CI) = 1.1893 [1.0823-1.3070], p = 0.0046}. A negative causal association with the risk of CD was found for immunosuppressants {OR (95% CI) = 0.6957 [0.5803-0.8341], p = 0.0023}. There was no statistically significant association between the remaining 19 drugs and IBD and subtypes., Conclusion: This MR study provides evidence suggesting that immunosuppressants have a mitigating effect on the risk of IBD and demonstrate consistent efficacy in subtypes of ulcerative colitis (UC) and Crohn's disease (CD). Additionally, diabetes medications show potential in reducing the risk of IBD, particularly in cases of UC, while β-blockers may elevate the risk of UC. Conversely, salicylic acid and its derivatives may increase the risk of IBD, although this effect is not consistently observed in the subtypes of the disease. These findings offer new insights into the prevention and management of IBD., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 He, Deng, Huang, Yang, Yang and Song.)
- Published
- 2024
- Full Text
- View/download PDF
142. [Cuiru Keli Improves Postpartum Hypogalactia in Rats Through Secreted Frizzled-Related Protein 2-Wnt/β-catenin Signaling Pathway].
- Author
-
Xue Q, Huang Y, Li H, Li C, Cheng C, Wang Y, and Miao C
- Subjects
- Animals, Female, Rats, Rats, Sprague-Dawley, Pregnancy, beta Catenin metabolism, beta Catenin genetics, Wnt Signaling Pathway drug effects, Drugs, Chinese Herbal pharmacology, Postpartum Period metabolism
- Abstract
Objective: Based on the secreted frizzled-related protein 2 (SFRP2)-Wnt/β-catenin signaling pathway, this study explored the effect and mechanism of Cuiru Keli (CRKL) in the treatment of postpartum hypogalactia., Methods: A rat model of postpartum hypogalactia was established by gavaging 2 mL of 1.6 mg/mL bromocriptine mesylate to female rats on the third day after delivery. Female rats with a delivery time difference of less than 48 hours were selected and randomly assigned to 7 groups, including a normal group (without any modeling or medication), a model group, a CRKL low-dose group of model group model rats receiving CRKL at the dose of 3 g/kg, a CRKL medium-dose group of model rats receiving CRKL at the dose of 6 g/kg, a CRKL high-dose group of model rats receiving CRKL at the dose of 9 g/kg, a positive drug group of model rats receiving domperidone at the dose of 3 mg/kg, and a negative control (NC) group of model rats receiving normal saline. Each group contained 6 rats. Except for the normal and model groups, the remaining 5 groups were continuously administered with the respective intervention drugs at the specified doses by gavage once a day for 10 days. Changes in the total litter mass of the offspring in the 7 groups within 10 days were measured, and HE staining was performed to identify pathological changes in the mammary tissue (MT). Six groups of rats (excluding the positive control group) were used to observe the pathological changes of eosinophils in pituitary tissue. ELISA was performed to determine the content of prolactin (PRL) in serum, immunohistochemical staining was used to determine the expression of prolactin receptor (PRLR) in MT, and RT-qPCR was used to determine the mRNA expression of genes related to lactation in MT. Network pharmacology and molecular docking were used to study the therapeutic effect and mechanism of CRKL on postpartum hypogalactia, particularly whether it acted through the SFRP2-Wnt/β-catenin signaling pathway. The mechanism of CRKL treatment was further validated by detecting mRNA (RT-qPCR) and protein expression (Western blot) of related pathway genes. Cell experiments were conducted using primary culture rat mammary epithelial cells (RMEC) from rat MT. RMEC were divided into four groups, including a normal group (primary culture RMEC, untreated), SFRP2 overexpression group (primary cultured RMEC treated with SFRP2 overexpression vector), SFRP2 overexpression+CRKL group (receiving treatment for SFRP2 overexpression group plus 10% drug-containing serum), and negative control group (primary culture RMEC treated with empty vector). The effect of CRKL on the expression of lactation-related genes FASN , CSN2 , and GLUT1 mRNA after SFRP2 overexpression was detected by RT-qPCR., Results: In this study, CRKL was administered at a dose of 3 g/kg in the CRKL low-dose group, 6 g/kg in the medium-dose group, and 9 g/kg in the high-dose group ( P <0.05 or P <0.01). Compared with the model group, CRKL at all doses significantly increased the total litter weight gain of the offsprings within 10 days ( P <0.05 or P <0.01), and effectively increased lactation ( P <0.01), the area of mammary lobules, and the size and filling of acinar cavities. CRKL at all doses also increased the number of eosinophils that secreted PRL in the pituitary gland of the postpartum hypogalactia rat model, and increased the content of PRL in the serum ( P <0.05 or P <0.01). CRKL promoted the secretion and expression of PRL in postpartum hypogalactic model rats. In addition, it significantly promoted the expression of genes related to milk fat, milk protein, and lactose synthesis in MT ( P <0.05 or P <0.01). Network pharmacology predicted that the Wnt signaling pathway might be a key pathway for CRKL in treating postpartum hypogalactia. The molecular docking results showed that related chemical components in CRKL had good binding ability with CCND1 and SFRP2. Compared with the model group, CRKL at all doses inhibited the expression of SFRP2 gene in vivo ( P <0.01) and activated the mRNA and protein expression of CCND1 and c-Myc in the Wnt/β-catenin signaling pathway in MT ( P <0.05 or P <0.01). Cell experiments showed that, compared to the normal group, SFRP2 overexpression reduced the mRNA expression of milk synthesis-related genes FASN , CSN2 , and GLUT1 in RMEC ( P <0.01). The CCK8 results indicated that 10% of the drug-containing serum was the effective concentration administered to cells ( P <0.01). After administering drug-containing serum, the expression of the lactation-related genes FASN , CSN2 , and GLUT1 were up-regulated (compared with the SFRP2 overexpression group, P <0.01)., Conclusion: CRKL alleviates postpartum hypogalactia through the SFRP2-Wnt/β-catenin signaling pathway. SFRP2 might be a potential new target for the diagnosis and treatment of postpartum hypogalactia. This reveals a new mechanism of CRKL in treating postpartum hypogalactia and promotes its clinical application., Competing Interests: 利益冲突 所有作者均声明不存在利益冲突, (© 2024《四川大学学报(医学版)》编辑部 版权所有Copyright ©2024 Editorial Office of Journal of Sichuan University (Medical Sciences).)
- Published
- 2024
- Full Text
- View/download PDF
143. Fat mass and obesity-associated protein inhibit the pathology of rheumatoid arthritis through the NSUN2/SFRP1/Wnt/β-catenin signal axis.
- Author
-
Huang Y, Xu P, Liao F, Ca H, Wang X, Wang X, Chang J, and Miao C
- Subjects
- Humans, Rats, Animals, beta Catenin metabolism, Gene Expression Regulation, Wnt Signaling Pathway, Obesity, Membrane Proteins genetics, Membrane Proteins metabolism, Intercellular Signaling Peptides and Proteins genetics, Intercellular Signaling Peptides and Proteins metabolism, Methyltransferases genetics, Methyltransferases metabolism, Alpha-Ketoglutarate-Dependent Dioxygenase FTO genetics, Alpha-Ketoglutarate-Dependent Dioxygenase FTO metabolism, Arthritis, Rheumatoid pathology, Arthritis, Experimental
- Abstract
Objectives: The purpose of this study is to investigate whether fat mass and obesity-associated protein (FTO) and NOL1/NOP2/Sun domain family member 2 (NSUN2) mediated RNA methylation is associated with RA pathology., Methods: We studied the anti-rheumatoid arthritis (RA) mechanism mediated by FTO and NSUN2 in RA samples and collagen-induced arthritis (CIA) rats using real time qPCR (RT-qPCR), western blot, immunofluorescence, and other methods., Key Findings: The expression of NSUN2 was significantly increased in both RA patients and CIA rats compared with normal controls. Knockdown of NSUN2 blocked the Wnt/β-catenin signaling pathway and inhibited RA pathological factors such as MMP3, fibronectin, and interleukins. FTO overexpression inhibited RA by inhibiting the expression of NSUN2, up-regulating the level of SFRP1 protein, and blocking the Wnt/β-catenin signaling pathway. NSUN2 overexpression interfered with the inhibitory effects of FTO on the Wnt/β-catenin signaling pathway and RA pathology, which further verified that FTO inhibited RA through the NSUN2/SFRP1/Wnt/β-catenin signal axis., Conclusions: FTO and NSUN2 are important factors of RA, and this work provides new potential diagnostic biomarkers and therapeutic targets for RA. We also reveal a gene expression regulation pattern of the interaction between m6A and m5C. revealing the pathogenesis of RA from the perspective of RNA methylation., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
144. Associations between rheumatoid arthritis and intestinal flora, with special emphasis on RA pathologic mechanisms to treatment strategies.
- Author
-
Peng Y, Huang Y, Li H, Li C, Wu Y, Wang X, Wang Q, He J, and Miao C
- Subjects
- Humans, Intestines, Inflammation, Gastrointestinal Microbiome, Arthritis, Rheumatoid drug therapy, Autoimmune Diseases
- Abstract
Background: Rheumatoid arthritis (RA) is an autoimmune inflammatory disease that primarily affects the joints. Individuals at risk for RA and people with RA develop intestinal dysbiosis. The changes in intestinal flora composition in preclinical and confirmed RA patients suggest that intestinal flora imbalance may play an important role in the induction and persistence of RA., Methods: Based on the current research on the interaction between RA and intestinal microbiota, intestinal microbiota metabolites and intestinal barrier changes. This paper systematically summarized the changes in intestinal microbiota in RA patients, the metabolites of intestinal flora, and the influence mechanism of intestinal barrier on RA, and further discussed the influence of drugs for RA on intestinal flora and its mechanism of action., Results: Compared with healthy controls, α diversity analysis of intestinal flora showed no significant difference, β diversity analysis showed significant differences. The intestinal flora produces bioactive metabolites, such as short-chain fatty acids and aromatic amino acids, which have anti-inflammatory effects. Abnormal intestinal flora leads to impaired barrier function and mucosal immune dysfunction, promoting the development of inflammation. Traditional Chinese medicine (TCM) and chemical drugs can also alleviate RA by regulating intestinal flora, intestinal flora metabolites, and intestinal barrier. Intestinal flora is closely related to the pathogenesis of RA and may become potential biomarkers for the diagnosis and treatment of RA., Conclusions: Intestinal flora and its metabolites play an important role in the pathogenesis of autoimmune diseases such as RA, and are expected to become a new target for clinical diagnosis and treatment, providing a new idea for targeted treatment of RA., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
145. Wilforine inhibits rheumatoid arthritis pathology through the Wnt11/β-catenin signaling pathway axis.
- Author
-
Huang Y, Peng Y, Li H, Li C, Wu Y, Wang X, Chang J, and Miao C
- Subjects
- Rats, Animals, beta Catenin metabolism, Glycogen Synthase Kinase 3 beta metabolism, Glycogen Synthase Kinase 3 beta pharmacology, Cell Proliferation, Wnt Signaling Pathway, Fibroblasts metabolism, Cells, Cultured, Synovial Membrane metabolism, Wnt Proteins metabolism, Arthritis, Rheumatoid metabolism, Synoviocytes metabolism, Arthritis, Experimental metabolism
- Abstract
Background: Wilforine (WFR) is a monomeric compound of the anti-RA plant Tripterygium wilfordii Hook. f. (TwHF). Whether WFR has anti-RA effect, its molecular mechanism has not been elucidated., Aim of the Study: Our study aims to clarify how WFR inhibits fibroblast-like synovial cells (FLS) activation and improves RA through Wnt11 action on the Wnt11/β-catenin signaling pathway., Methods: The therapeutic effect of WFR on collagen-induced arthritis (CIA) rats was evaluated using methods such as rat arthritis score. The inhibitory effects and signaling pathways of WFR on the proliferation and inflammatory response of CIA FLS and RA FLS were studied using ELISA, CCK-8, RT-qPCR, Western blot, and immunofluorescence methods., Results: WFR could effectively alleviate the arthritis symptoms of CIA rats; reduce the levels of IL-6, IL-1β, and TNF-α in the peripheral blood of CIA rats; and inhibit the expression of MMP3 and fibronectin. The data showed that WFR has a significant inhibitory effect on FLS proliferation. Furthermore, WFR inhibited the activation of Wnt/β-catenin signaling pathway and decreased the expression of Wnt11, β-catenin, CCND1, GSK-3β, and c-Myc, while the effects of WFR were reversed after overexpression of Wnt11., Conclusions: WFR improves RA by inhibiting the Wnt11/β-catenin signaling pathway, and Wnt11 is the direct target of WFR. This study provides a new molecular mechanism for WFR to improve RA and contributes to the clinical promotion of WFR., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
146. Wnt5a: A promising therapeutic target for inflammation, especially rheumatoid arthritis.
- Author
-
Huang Y, Xue Q, Chang J, Wang X, and Miao C
- Subjects
- Humans, Wnt-5a Protein, Inflammation metabolism, Wnt Signaling Pathway, Fibroblasts metabolism, Cells, Cultured, Arthritis, Rheumatoid metabolism, Sepsis metabolism
- Abstract
Background: Wnt5a is a member of the Wnt protein family, which acts on classical or multiple non-classical Wnt signaling pathways by binding to different receptors. The expression regulation and signal transduction of Wnt5a is closely related to the inflammatory response. Abnormal activation of Wnt5a signaling is an important part of inflammation and rheumatoid arthritis (RA)., Objectives: This paper mainly focuses on Wnt5a protein and its mediated signaling pathway, summarizes the latest research progress of Wnt5a in the pathological process of inflammation and RA, and looks forward to the main directions of Wnt5a in RA research, aiming to provide a theoretical basis for the prevention and treatment of RA diseases by targeting Wnt5a., Results: Wnt5a is highly expressed in activated blood vessels, histocytes and synoviocytes in inflammatory diseases such as sepsis, sepsis, atherosclerosis and rheumatoid arthritis. It mediates the production of pro-inflammatory cytokines and chemokines, regulates the migration and recruitment of various immune effector cells, and thus participates in the inflammatory response. Wnt5a plays a pathological role in synovial inflammation and bone destruction of RA, and may be an important clinical therapeutic target for RA., Conclusion: Wnt5a is involved in the pathological process of inflammation and interacts with inflammatory factors. Wnt5a may be a new target for regulating the progression of RA disease and intervening therapy because of its multi-modal effects on the etiology of RA, especially as a regulator of osteoclast activity and inflammation., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
147. An Analysis of Infection Prevention and Control Practices in Designated Hospitals that Treat COVID-19: A Systematic Review and Meta-Analysis.
- Author
-
Zhu Y, Zhao X, Guo Y, Li W, Pan Y, Zhuang J, Zhou J, and Huang Y
- Subjects
- Humans, COVID-19 Drug Treatment, SARS-CoV-2, Hospitals, COVID-19 prevention & control, Drugs, Chinese Herbal therapeutic use
- Abstract
Objective: The present investigation aims to conduct a comprehensive examination of the infection prevention and control efforts in hospitals of Xinjiang Production and Construction Corps designated for COVID-19 treatment., Methods: By searching the Cochrane Library, PubMed, Embase, Chinese Academic Journal, Full Text Database, Chinese Biomedical Literature Database (CBM), VIP Chinese Scientific, Web of Science, Chinese National Knowledge Infrastructure (CNKI), Wanfang Database (CECDB), and using Review Manager 5.2 software, the quality assessment, data extraction, and meta-analysis were carried out for the included literature., Results: Between both the experimental and the control groups, there was a statistically significant difference in the level of public awareness of COVID-19 prevention and control [OR = 1.61, 95% confidence interval (CI) (1.31, 1.99), P < .00001, I2 = 32%, Z = 4]; public concern about COVID-19 prevention and control [OR = 1.56, 95% CI (1.28, 1.90), P < .0001, I2 = 0%, Z = 4.35]; public anxiety on COVID-19 prevention and control [OR = 1.67, 95% CI (1.37, 2.03), P < .00001, I2 = 32%, Z = 5.13]., Conclusion: Chinese prophylaxis and controlling measures for COVID-19 are mainly to protect vulnerable populations, cut off transmission routes, and control the source of infection. Therefore, we must also do our best to prevent and control novel coronavirus pneumonia to protect our health and reduce the burden on our country.
- Published
- 2023
148. M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics.
- Author
-
Huang Y, Xue Q, Chang J, Wang Y, Cheng C, Xu S, Wang X, and Miao C
- Subjects
- Humans, Methylation, Epigenesis, Genetic genetics, Autoimmune Diseases diagnosis, Autoimmune Diseases genetics, Autoimmune Diseases therapy, Arthritis, Rheumatoid diagnosis, Arthritis, Rheumatoid genetics, Arthritis, Rheumatoid therapy, Lupus Erythematosus, Systemic diagnosis, Lupus Erythematosus, Systemic genetics, Lupus Erythematosus, Systemic therapy
- Abstract
Background: N6-methyladenosine (m6A) methylation modification is involved in the regulation of various biological processes, including inflammation, antitumor, and antiviral immunity. However, the role of m6A modification in the pathogenesis of autoimmune diseases has been rarely reported., Methods: Based on a description of m6A modification and the corresponding research methods, this review systematically summarizes current insights into the mechanism of m6A methylation modification in autoimmune diseases, especially its contribution to rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)., Results: By regulating different biological processes, m6A methylation is involved in the pathogenesis of autoimmune diseases and provides a promising biomarker for the diagnosis and treatment of such diseases. Notably, m6A methylation modification is involved in regulating a variety of immune cells and mitochondrial energy metabolism. In addition, m6A methylation modification plays a role in the pathological processes of RA, and m6A methylation-related genes can be used as potential targets in RA therapy., Conclusions: M6A methylation modification plays an important role in autoimmune pathological processes such as RA and SLE and represents a promising new target for clinical diagnosis and treatment, providing new ideas for the treatment of autoimmune diseases by targeting m6A modification-related pathways., (© 2023. BioMed Central Ltd., part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
149. Dysregulation of circRNAs in rheumatoid arthritis, with special emphasis on circRNAs secreted by exosomes and the crosstalk between circRNAs and RNA methylations.
- Author
-
Wang Y, Huang Y, Cheng C, Xue Q, Chang J, Wang X, Duan Q, and Miao C
- Subjects
- Humans, RNA, Circular genetics, RNA, Circular metabolism, Methylation, Leukocytes, Mononuclear metabolism, Cell-Free Nucleic Acids metabolism, Exosomes genetics, Exosomes metabolism, MicroRNAs genetics, MicroRNAs metabolism, Arthritis, Rheumatoid metabolism, Synoviocytes metabolism
- Abstract
Background: Rheumatoid arthritis (RA) is an autoimmune disease caused by a variety of unknown factors. It mainly occurs in the small joints of hands and feet, leading to cartilage destruction and bone erosion. Various pathologic mechanisms such as exosomes and RNA methylations are involved in the pathogenesis of RA., Methods: This work searches PubMed, Web of Science (SCIE) and Science Direct Online (SDOL) databases, it role of abnormally expressed circulating RNAs (circRNAs) in the pathogenesis of RA was summarized. And the relationship between circRNAs and exosomes and methylations., Results: Both the abnormal expression of circRNAs and the sponge effect of circRNAs on microRNAs (miRNAs) affect the pathogenesis of RA by regulating target genes. CircRNAs affect the proliferation, migration and inflammatory reaction of RA-fibroblast-like synovial cells (FLSs), circRNAs in peripheral blood mononuclear cells (PBMCs) and macrophages also participate in the pathological mechanism of RA (Fig. 1). CircRNAs in exosomes are closely related to the pathogenesis of RA. In addition, exosomal circRNAs and the relationship between circRNAs and RNA methylations are closely related to the pathogenesis of RA., Conclusion: CircRNAs play an important role in the pathogenesis of RA and have the potential to be a new target for the diagnosis and treatment of RA. However, the development of mature circRNAs for clinical application is not a small challenge., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
150. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
- Author
-
Xiao Y, Yin C, Wang Y, Lv H, Wang W, Huang Y, Perez-Losada J, Snijders AM, Mao JH, and Zhang P
- Subjects
- Animals, Carcinogenesis drug effects, Carcinogenesis genetics, Carcinoma, Non-Small-Cell Lung genetics, Carcinoma, Non-Small-Cell Lung pathology, Cell Line, Tumor, Cell Movement drug effects, Disease Susceptibility, Down-Regulation drug effects, Drug Resistance, Neoplasm drug effects, Epithelial-Mesenchymal Transition drug effects, F-Box-WD Repeat-Containing Protein 7 deficiency, Gene Expression Regulation, Neoplastic drug effects, Gene Knockdown Techniques, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Invasiveness, Prognosis, Sirolimus pharmacology, TOR Serine-Threonine Kinases metabolism, Treatment Outcome, Carcinogenesis pathology, Drug Resistance, Neoplasm genetics, F-Box-WD Repeat-Containing Protein 7 genetics, Gefitinib pharmacology, Gene Deletion, Lung Neoplasms genetics, Lung Neoplasms pathology
- Abstract
Gefitinib, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), is an effective treatment for non-small-cell lung cancer (NSCLC) with EGFR activating mutations, but inevitably, the clinical efficacy is impeded by the emergence of acquired resistance. The tumor suppressor gene FBXW7 modulates chemosensitivity in various human cancers. However, its role in EGFR-TKI therapy in NSCLC has not been well studied. Here, we demonstrate that the mice with deficient Fbxw7 have greater susceptibility to urethane-induced lung tumor development. Through analysis of The Cancer Genome Atlas data, we show that deletion of FBXW7 occurs in 30.9% of lung adenocarcinomas and 63.5% of lung squamous cell carcinomas, which significantly leads to decrease in FBXW7 mRNA expression. The reduction in FBXW7 mRNA level is associated with poor overall survival in lung cancer patients. FBXW7 knockdown dramatically promotes epithelial-mesenchymal transition, migration, and invasion in NSCLC cells. Moreover, with silenced FBXW7, EGFR-TKI-sensitive cells become resistant to gefitinib, which is reversed by the mammalian target of rapamycin inhibitor, rapamycin. Furthermore, xenograft mouse model studies show that FBXW7 knockdown enhances tumorigenesis and resistance to gefitinib. Combination of gefitinib with rapamycin treatment suppresses tumor formation of gefitinib-resistant (GR) FBXW7-knockdown cells. In conclusion, our findings suggest that loss of FBXW7 promotes NSCLC progression as well as gefitinib resistance and combination of gefitinib and rapamycin may provide an effective therapy for GR NSCLC., (© 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.